Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
1 mg
5 mg
10 mg
1 mM
0.8983 mL
4.4916 mL
8.9833 mL
5 mM
0.1797 mL
0.8983 mL
1.7967 mL
10 mM
0.0898 mL
0.4492 mL
0.8983 mL
50 mM
0.0180 mL
0.0898 mL
0.1797 mL
Description
Pibrentasvir (ABT-530) is a novel and pan-genotypic inhibitor with EC50 ranging from 1.4 pM to 5.0 pM against HCV replicons containing NS5A from genotypes 1 to 6.
Targets
In vitro
Pibrentasvir is a next-generation HCV NS5A inhibitor with potent and pan-genotypic activity, and it maintains activity against common amino acid substitutions of HCV genotypes 1 to 6 that are known to confer resistance to currently approved NS5A inhibitors.
